Consulting Services


Optimus Pharma Consulting is a drug development consulting and advisory firm focused on providing business support through the entire lifecycle of business processes and other complex transactions of the Life Sciences industry.

Optimus provides life sciences companies and investors with a new approach to consulting and due diligence. The core of our professional approach is that customer focused best advice requires both rigorous scientific and technical expertise and a keen understanding for critical business and operational considerations. Our experts have proven track records in both strategy and implementation. We bring the rare ability to integrate understanding of executive level business objectives with grass root level implementation.

Optimus Pharma Consulting provides its customers with data, information and insight(Business, Science, Regulations) to help shape product development plans: pharmaceuticals, biologics, biosimilars, medical devices / combination products, fixed dose combinations, veterinary products, herbal products, food products etc.,. We then provide expert resources, time tested processes and methodology to help propel your products over early stage hurdles, past key milestones, and on to first-cycle approvals.

Integrating Science, Regulations and Measurable Business outcomes, combining local knowledge with global standards, our team moves beyond providing expert advise to get your project off the ground and moving at a fast pace.

Optimus developed and well tested implementation methodology generates significant business gains on all implemented projects by ensuring, at each stage of project implementation lifecycle, a focus on impacts and results for both business and functional stakeholders. The business consulting approach and impeccable process implementation and delivery practices ensure that optimal business solutions are implemented to achieve specified business objectives,strategically.



  • Projects tracked in real time, delivered on schedule within service levels agreed upon reducing development costs;
  • Providing, localized strategic and process expertise to attain business competitiveness delivering faster, quicker, approvable projects;
  • Faster design, planning and implementation processes leading to increased ROI;
  • Improved regulatory compliance;
  • Improved drug development productivity, risk mitigation, increased revenue.